Pfizer and Moderna vaccines produce robust immune responses in women who are pregnant or nursing
The findings come from a small study conducted at Beth Israel Deaconess in Boston.
By Jonathan Saltzman Globe Staff,Updated May 13, 2021, 11:23 a.m.
Email to a Friend
Dr. Dan Barouch, head of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center, is the senior author of the new study.Lane Turner/Globe Staff
Women who received the Pfizer-BioNTech or Moderna coronavirus vaccines while pregnant or nursing had immune responses as robust as those of other vaccinated women and appeared to pass antibodies to their infants through blood and breast milk, according to a small study at Beth Israel Deaconess Medical Center.
Modernaâs CEO says he âdidnât lose a minute of sleepâ over potential waiver of vaccine patents
By Jonathan Saltzman Globe Staff,Updated May 6, 2021, 8:39 p.m.
Email to a Friend
Modernaâs production and lab facility in Norwood is doubling in size.John Tlumacki/Globe Staff
Moderna chief executive Stephane Bancel on Thursday shrugged off the Biden administrationâs support for suspending patents for coronavirus vaccines, saying drug firms in other countries would struggle to mass-produce a rival to the blockbuster vaccine that has made his company a household name.
Speaking during a first-quarter earnings call, the head of the Cambridge biotech said he âdidnât lose a minute of sleepâ after the administration said it would endorse the temporary waiver of patents to bolster vaccine production in developing nations
House Democrats who received the most donations from the pharmaceutical industry are declining to support a push to release the patents on COVID-19 vaccines to developing countries, even as Pfizer reports soaring revenue from its vaccine.
Pfizer on Tuesday reported $3.46 billion in first-quarter vaccine sales in all but three countries. BioNTech, which which it splits vaccine costs and profit, will report the remaining revenue on May 10.
The company almost doubled its sales projections for the COVID-19 vaccine this year, from $15 billion to roughly $26 billion, citing strong demand for its vaccine.
Meanwhile, the nine House Democrats among Congress s top 25 recipients of donations from pharmaceutical industry PACs have all declined to sign on to a letter urging the Biden administration to waive intellectual property rights for the vaccine to let developing countries produce their own supply, according to the Huffington Post.
Biden throws support behind waiving intellectual property protections for Covid vaccines to allow hard-hit countries like India and South Africa to make copycat shots
The Biden administration said on Wednesday it supports waiving intellectual property protections for vaccine makers like Pfizer and Moderna
Without waiving these patent rights, countries like South African and India cannot manufacture the shots The Administration believes strongly in intellectual property protections, but in service of ending this pandemic, supports the waiver of those protections for COVID-19 vaccines, said US Trade Representative Katherine Tai in a statement
The World Trade Organization has urged counties to waive patent protection